CRISIL Ltd. Valuation Shifts to Very Expensive Amid Mixed Returns

Valuation Metrics Reflect Elevated Price Levels

CRISIL’s current P/E ratio of 37.54 positions it firmly in the "very expensive" category, a significant increase from previous levels that had warranted a "hold" rating. This elevated P/E ratio suggests that investors are paying a substantial premium for each rupee of earnings, which may not be fully justified given the company’s recent performance and broader market conditions. The price-to-book value ratio of 10.39 further underscores this premium valuation, indicating that the stock is trading at over ten times its net asset value.

Other valuation multiples reinforce this trend. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 26.55, while the EV to EBIT ratio is 30.14, both figures well above typical sector averages. These multiples suggest that the market is pricing in robust future earnings growth and operational efficiency, expectations that may be challenging to meet in the current economic environment.

Financial Performance and Returns in Context

Despite the lofty valuations, CRISIL’s return on capital employed (ROCE) remains impressive at 40.73%, and return on equity (ROE) is a healthy 25.25%. These metrics indicate strong operational efficiency and profitability, which have historically supported premium valuations. However, the stock’s recent returns paint a more nuanced picture. Over the past year, CRISIL’s share price has declined by 26.38%, significantly underperforming the Sensex, which fell by 5.75% over the same period. This underperformance raises questions about the sustainability of the current valuation levels.

Year-to-date, the stock has marginally declined by 0.53%, while the Sensex has dropped 9.09%, suggesting some resilience in the face of broader market weakness. Over longer horizons, CRISIL has delivered a 10.44% return over three years and 43.61% over five years, though these figures lag behind the Sensex’s respective returns of 16.17% and 48.41%. The ten-year return of 107.24% also trails the benchmark’s 179.57%, indicating that while CRISIL has been a solid performer, it has not consistently outpaced the broader market.

Market Capitalisation and Trading Range

CRISIL is classified as a mid-cap stock, with a current market price of ₹4,302.10, up 1.56% from the previous close of ₹4,235.85. The stock’s 52-week trading range spans from ₹3,689.00 to ₹5,899.50, reflecting considerable volatility. Today’s intraday range between ₹4,229.00 and ₹4,340.00 suggests moderate trading activity, with the price hovering closer to the lower end of its recent range, possibly indicating some investor caution amid valuation concerns.

Mojo Score and Rating Downgrade

Reflecting the shift in valuation and price attractiveness, CRISIL’s Mojo Score currently stands at 48.0, accompanied by a Mojo Grade of "Sell." This represents a downgrade from the previous "Hold" rating, effective from 21 July 2026. The downgrade signals increased caution among analysts and investors, highlighting concerns that the stock’s elevated valuation may not be supported by near-term earnings growth or market conditions.

The downgrade also aligns with the company’s "very expensive" valuation status, as assessed by MarketsMOJO’s comprehensive grading system. This system integrates multiple financial metrics, including P/E, EV/EBITDA, PEG ratio, and dividend yield, to provide a holistic view of the stock’s investment appeal.

Dividend Yield and Growth Prospects

CRISIL’s dividend yield currently stands at 1.44%, a modest figure that may not sufficiently compensate investors for the elevated valuation risk. The PEG ratio of 1.99 suggests that the stock’s price growth is nearly double its earnings growth rate, further emphasising the premium investors are paying for future growth expectations.

While the company’s strong ROCE and ROE metrics indicate operational strength, the market’s tempered returns over recent years and the high valuation multiples suggest that investors should carefully weigh the risk-reward balance before committing fresh capital.

Comparative Analysis with Peers and Sector

Within the capital markets sector, CRISIL’s valuation multiples are notably higher than many of its peers, which typically trade at more moderate P/E and EV/EBITDA ratios. This divergence may reflect the market’s confidence in CRISIL’s brand, market position, and growth prospects, but it also raises the risk of a valuation correction should earnings disappoint or broader market sentiment shift.

Investors should consider the relative attractiveness of alternative stocks in the sector, especially those with more reasonable valuations and comparable growth potential. The current premium pricing of CRISIL warrants a cautious approach, particularly given the stock’s recent underperformance relative to the Sensex.

Investor Takeaway

CRISIL Ltd.’s recent valuation shift to "very expensive" territory, combined with a downgrade to a "Sell" rating, signals a need for investors to exercise caution. While the company’s operational metrics remain robust, the premium multiples and recent price underperformance relative to the Sensex suggest that the stock may be vulnerable to a correction if growth expectations are not met.

Investors should carefully assess their portfolio exposure to CRISIL, considering both the company’s strengths and the elevated valuation risks. Diversification into more attractively valued peers or sectors may offer a more balanced risk-return profile in the current market environment.

Given the stock’s mid-cap status and the volatility observed in its trading range, timing and price discipline will be critical for those considering entry or exit points.

Summary of Key Financial Metrics

To recap, CRISIL’s key valuation and financial metrics as of 22 July 2026 are:

• P/E Ratio: 37.54 (Very Expensive)
• Price to Book Value: 10.39
• EV to EBIT: 30.14
• EV to EBITDA: 26.55
• PEG Ratio: 1.99
• Dividend Yield: 1.44%
• ROCE: 40.73%
• ROE: 25.25%
• Mojo Score: 48.0 (Sell)

These figures collectively highlight the stock’s premium valuation and the cautious stance adopted by analysts.

Conclusion

CRISIL Ltd. remains a well-established entity within the capital markets sector, boasting strong profitability and operational efficiency. However, the recent valuation expansion to very expensive levels, coupled with a downgrade in investment grade, suggests that investors should reassess the stock’s price attractiveness. The risk of valuation correction is heightened, especially in a market environment marked by volatility and shifting investor sentiment.

Prudent investors may consider monitoring the stock closely for signs of earnings momentum or valuation moderation before increasing exposure. Meanwhile, exploring alternative investment opportunities within the sector or across market caps could provide more favourable risk-adjusted returns.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →